Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Rare Move, CMS Cites FDA Warning Letter In National Coverage Request

This article was originally published in The Gray Sheet

Executive Summary

CMS' internally-generated national coverage request for infrared therapy devices uncharacteristically refers to a recent FDA warning letter to manufacturer Anodyne Therapy

You may also be interested in...



Sen. Grassley Wants FDA To Give More Info To CMS, Cites Menaflex Case

Controversy over FDA's 2008 clearance of ReGen Biologics' Menaflex knee repair device has now expanded into questions from Congress over how effectively FDA shares information with its sister agency CMS

Sen. Grassley Wants FDA To Give More Info To CMS, Cites Menaflex Case

Controversy over FDA's 2008 clearance of ReGen Biologics' Menaflex knee repair device has now expanded into questions from Congress over how effectively FDA shares information with its sister agency CMS

CMS Contemplates Role Of Responding To Device Safety Concerns

CMS is pondering its responsibility to repeal coverage for medical services or devices when safety concerns surface, leading some to question whether such action could infringe on FDA turf

Related Content

Latest News
See All
UsernamePublicRestriction

Register

MT023184

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel